Fraser Health Foot Care Project Shows Reduced Amputation, Hospitalization and Length of Stay in Dialysis Patients

Daniel Schwartz
Daniel SchwartzNephrologist & QxMD Medical Director at Fraser Health
2015
Foot Care Initiative in Dialysis Patients
Fraser Health Authority
Dr Shaoyee Yao
Background
Burden of Lower Limb disease
Lower limb disease
affects 30-40% of
prevalent dialysis
patients
Ndip,A et al. Diabetes Care 2010
Background
Lower limb disease associated with significant morbidity
and mortality in dialysis patients
Orimoto et al. J Vasc Surg 2013
5 year survival:
43%
(CORR Data 2010)
5 year survival
with foot lesion:
23%
Background
Kaminski M Et al. NDT 2015
Can we alter
these risk factors
to improve
outcomes ?
Project Intent
• To establish a multi disciplinary approach to early
detection and treatment of lower limb lesions in
patients with ESRD
Project Outline
Pilot at ARH over 2 years duration measuring
outcomes before and after intervention
Outcomes of interest:
1. Rates of limb amputation
2. Days of hospitalization per year
3. All cause mortality
Intervention
“Socks Off Week”
“Socks Off Week”
’60 Second’ Foot
assessment: performed on
all dialysis patients by Renal
RN every 6 weeks
Our “Clinic”
Preliminary Results
A
B
C
Hospitalization rate by complication – ARH HD + PD
Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%)
  n (%) n (%)
Lower Limb Infection  17 (8.9%) 8 (4.4%) (-) 9 ↓ 50.6%
Lower limb revascularization  4 (2.1%) 4 (2.2%) 0 ↑ 4.8%
Peripheral Vascular Disease  8 (4.2%) 12 (6.6%) (+) 4 ↑ 57.1%
Lower limb angiogram 1 (0.53%) 2 (1.1%) (+) 1 ↑ 108%
Hospitalization rate – discharges excluding
amputation
(Lower limb infection, LL revascularization, LL angiogram, PVD)
30 (15.8%) 26 (14.2%) (-) 4 ↓ 10.1%
Hospitalization rate - discharges including amputation 36 (18.9%) 32 (17.5%) (-) 4 ↓ 7.4%
Amputation Rate - ARH HD + PD
  Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%)
Amputation rate (# patients with amp event / total pts) 2.6% 1.6% --- ↓ 38.5%
Preliminary Results – 1
Decreased 687 
days in hospital 
for lower limb 
related 
admissions!
Hospitalization days - ARH HD + PD
Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%)
Total days (all events excluding amputation)  1080 834 (-) 246 ---
Hospital days Per person 5.68 4.56 --- ↓ 19.7%
Total days (all events including amputation) 1718 1031 (-) 687 ---
Hospital days Per person 9.04 5.63 --- ↓ 37.7%
Average Length of Stay - ARH HD + PD
Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference
Amputation only 36.0 32.1 (-) 3.9
Other reasons  (Lower limb infection, Lower limb 
Revascularization, Lower limb Angiogram, PVD)
106.3 32.8 (-) 73.5
Hospitalization rate by complication - HD + PD
Post RCH + SMH (N=600) Post ARH (N=183) Absolute Difference Relative Difference (%)
  n (%) n (%)
Lower Limb Infection  51 (8.5%) 8 (4.4%) --- ↓ 48.2%
Lower limb revascularization  26 (4.33%) 4 (2.2%) --- ↓ 49.2%
Peripheral Vascular Disease  39 (6.5%) 12 (6.6%) --- ↑ 1.5%
Lower limb angiogram 4 (.7%) 2 (1.1%) --- ↑ 44.7%
Hospitalization rate – discharges excluding
amputation
(Lower limb infection, LL revascularization, LL angiogram, PVD)
120 (20.0%) 26 (14.2%) --- ↓ 29.0%
Hospitalization rate - discharges including amputation 145 (24.2%) 32 (17.5%) --- ↓ 27.7%
Amputation Rate - HD + PD
  Post RCH + RCH (N=600) Post ARH (N=183) Absolute Difference Relative Difference (%)
Amputation rate (# patients with amp event / total pts) 3.0% 1.6% --- ↓ 46.7%
Preliminary Results - 2
Hospitalization days - HD + PD
Post RCH + SMH
(N=600)
Post ARH (N=183) Absolute Difference Relative Difference (%)
Total days (all events excluding amputation)  4362 834   ---
Hospital days Per person 7.27 4.56 --- ↓ 37.3%
Total days (all events including amputation) 5914 1031   ---
Hospital days Per person 9.86 5.63 --- ↓ 42.9%
Average Length of Stay - HD + PD
Post RCH + SMH (N=600) Post ARH (N=183) Absolute Difference
Amputation only 62.1 32.8 (-) 29.3
Other reasons  (Lower limb infection, Lower limb 
Revascularization, Lower limb Angiogram, PVD)
36.4 32.1 (-) 4.3
Preliminary Results -3
Mortality 
ARH Pre
Intervention
RCH + SMH Post
ARH Post
Intervention
N= 190 600 183
Event data end date 30-Nov-13
# Patients Deceased on or 
before event data end date
34 105 26
Rate 17.9% 17.5% 14.2%
30-Nov-14
Caveats
• Preliminary data without full statistical 
analysis (pending) 
• Short follow up of 1 year
– Longer intervention time likely to show greater 
improvements 
Costs 
Service Cost (Dec 1, 2013- Nov 30, 2014)
Podiatry:
 Partial MSP covered ($23 / visit) 
$150/new consult , $79/follow up 
$44 080.50
Unit Clerk  $1198.40
Nursing Project Coordinator 
(with hours for Nurse Champion)
$35 609.96
TOTAL $80 888.76
Next Steps
• Pilot continues until Dec 1, 2015 (2 years)
• Final data expected May 2016
• Expansion of intervention to SMH and RCH
• Perform cost benefit analysis
• Coordinate with the BCPRA to create a province
wide strategy
Thank You
• Sarah Lacroix (Project Coordinator)
• Dr Scott Schumacher (Podiatrist)
• Welman Lee, Dr Daniel Schwartz,
Ruth Burns, Jan Olsen
• All the Renal Nurses at ARH!!
Fraser Health Foot Care Project Shows Reduced Amputation, Hospitalization and Length of Stay in Dialysis Patients
1 of 18

Recommended

BC Kidney Days 2015 - Foot Care Nursing Breakout Session by
BC Kidney Days 2015 - Foot Care Nursing Breakout SessionBC Kidney Days 2015 - Foot Care Nursing Breakout Session
BC Kidney Days 2015 - Foot Care Nursing Breakout SessionDaniel Schwartz
3.9K views49 slides
Diabetic Foot 2016 by
Diabetic Foot 2016Diabetic Foot 2016
Diabetic Foot 2016AMNCH Vascular Surgery
1.7K views72 slides
Anesthesia 2011 by
Anesthesia 2011Anesthesia 2011
Anesthesia 2011praveenaJpnatc
1.1K views47 slides
Challenges in the diabetic foot 2016 by
Challenges in the diabetic foot 2016Challenges in the diabetic foot 2016
Challenges in the diabetic foot 2016AMNCH Vascular Surgery
657 views59 slides

More Related Content

What's hot(20)

Similar to Fraser Health Foot Care Project Shows Reduced Amputation, Hospitalization and Length of Stay in Dialysis Patients

Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy by
Treatment Of HCV in CKD Patients - Prof. Hussein El-FishawyTreatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-FishawyMNDU net
379 views101 slides
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp... by
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...Aalap Shah
447 views23 slides
Differences in clinical characteristics and its effect for outcomes by
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesdrucsamal
284 views24 slides
Percutaneous radial intervention dr gaurav chaudhary by
Percutaneous  radial intervention dr gaurav chaudhary  Percutaneous  radial intervention dr gaurav chaudhary
Percutaneous radial intervention dr gaurav chaudhary gauravchaudharydr
141 views34 slides

Similar to Fraser Health Foot Care Project Shows Reduced Amputation, Hospitalization and Length of Stay in Dialysis Patients(20)

Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy by MNDU net
Treatment Of HCV in CKD Patients - Prof. Hussein El-FishawyTreatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
MNDU net379 views
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp... by Aalap Shah
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Excerise Tolerance and Post-Operative Outcomes in Patients with Pulmonary Hyp...
Aalap Shah447 views
Differences in clinical characteristics and its effect for outcomes by drucsamal
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomes
drucsamal284 views
Percutaneous radial intervention dr gaurav chaudhary by gauravchaudharydr
Percutaneous  radial intervention dr gaurav chaudhary  Percutaneous  radial intervention dr gaurav chaudhary
Percutaneous radial intervention dr gaurav chaudhary
gauravchaudharydr141 views
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac... by hivlifeinfo
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
Clinical Impact of New HIV Data From the 2016 Comorbidities-Adverse Drug Reac...
hivlifeinfo1.8K views
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16 by Euro CTO Club
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Euro CTO Club649 views
POUR AANS 1226 presentation A. Bashee[1] by Azam Basheer
POUR AANS 1226 presentation A. Bashee[1]POUR AANS 1226 presentation A. Bashee[1]
POUR AANS 1226 presentation A. Bashee[1]
Azam Basheer277 views
How to manage delays in stroke treatment Jacek Staszewski by Jacek Staszewski
How to manage delays in stroke treatment Jacek StaszewskiHow to manage delays in stroke treatment Jacek Staszewski
How to manage delays in stroke treatment Jacek Staszewski
Jacek Staszewski292 views
Chronic Total Occlusions: The Road Less Traveled by Allina Health
Chronic Total Occlusions: The Road Less TraveledChronic Total Occlusions: The Road Less Traveled
Chronic Total Occlusions: The Road Less Traveled
Allina Health1.9K views
Unrelated Cord Blood Transplantation In Adults with Hematological Malignancie... by cordbloodsymposium
Unrelated Cord Blood Transplantation In Adults with Hematological Malignancie...Unrelated Cord Blood Transplantation In Adults with Hematological Malignancie...
Unrelated Cord Blood Transplantation In Adults with Hematological Malignancie...
What do we need to indicate CTO PCI? by Euro CTO Club
What do we need to indicate CTO PCI?What do we need to indicate CTO PCI?
What do we need to indicate CTO PCI?
Euro CTO Club604 views
Lecture on screening. Lund Okt 2008 by Jens Kondrup
Lecture on screening. Lund Okt 2008Lecture on screening. Lund Okt 2008
Lecture on screening. Lund Okt 2008
Jens Kondrup415 views
Benefits of RCA CTO-PCI Based on Clinical Data.pptx by Yamaguchi Yukihiro
Benefits of RCA CTO-PCI Based on Clinical Data.pptxBenefits of RCA CTO-PCI Based on Clinical Data.pptx
Benefits of RCA CTO-PCI Based on Clinical Data.pptx
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior by piodof
Treatment of pulmonary embolism data from registries - prof. Zbigniew GąsiorTreatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
Treatment of pulmonary embolism data from registries - prof. Zbigniew Gąsior
piodof739 views
Targeted therapy in ovarian cancer by Basalama Ali
Targeted therapy in ovarian cancerTargeted therapy in ovarian cancer
Targeted therapy in ovarian cancer
Basalama Ali1.6K views

Recently uploaded

Correct handling of laboratory Rats ppt.pptx by
Correct handling of laboratory Rats ppt.pptxCorrect handling of laboratory Rats ppt.pptx
Correct handling of laboratory Rats ppt.pptxTusharChaudhary99
32 views12 slides
Trustlife Türkiye - Güncel Platform Yapısı by
Trustlife Türkiye - Güncel Platform YapısıTrustlife Türkiye - Güncel Platform Yapısı
Trustlife Türkiye - Güncel Platform YapısıTrustlife
43 views2 slides
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad by
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Swetha rani Savala
22 views16 slides
Examining Pleural Fluid.pptx by
Examining Pleural Fluid.pptxExamining Pleural Fluid.pptx
Examining Pleural Fluid.pptxFareeha Riaz
21 views18 slides
MAINTAINING A HEALTHY LIFE.doc by
MAINTAINING A HEALTHY LIFE.docMAINTAINING A HEALTHY LIFE.doc
MAINTAINING A HEALTHY LIFE.docDr. MWEBAZA VICTOR
64 views13 slides
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx by
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCanadian Cancer Survivor Network
10 views36 slides

Recently uploaded(20)

Correct handling of laboratory Rats ppt.pptx by TusharChaudhary99
Correct handling of laboratory Rats ppt.pptxCorrect handling of laboratory Rats ppt.pptx
Correct handling of laboratory Rats ppt.pptx
Trustlife Türkiye - Güncel Platform Yapısı by Trustlife
Trustlife Türkiye - Güncel Platform YapısıTrustlife Türkiye - Güncel Platform Yapısı
Trustlife Türkiye - Güncel Platform Yapısı
Trustlife43 views
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad by Swetha rani Savala
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Fetal and Neonatal Circulation - MBBS, Gandhi medical College Hyderabad
Examining Pleural Fluid.pptx by Fareeha Riaz
Examining Pleural Fluid.pptxExamining Pleural Fluid.pptx
Examining Pleural Fluid.pptx
Fareeha Riaz 21 views
Gastro-retentive drug delivery systems.pptx by ABG
Gastro-retentive drug delivery systems.pptxGastro-retentive drug delivery systems.pptx
Gastro-retentive drug delivery systems.pptx
ABG233 views
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP by MohamadAlhes
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDPChronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP
MohamadAlhes89 views
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx by ABG
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ABG65 views
Complications & Solutions in Laparoscopic Hernia Surgery.pptx by Varunraju9
Complications & Solutions in Laparoscopic Hernia Surgery.pptxComplications & Solutions in Laparoscopic Hernia Surgery.pptx
Complications & Solutions in Laparoscopic Hernia Surgery.pptx
Varunraju9135 views
Pulmonary Embolism for Nurses.pptx by Asraf Hussain
Pulmonary Embolism for Nurses.pptxPulmonary Embolism for Nurses.pptx
Pulmonary Embolism for Nurses.pptx
Asraf Hussain36 views
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends by muskansbl01
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness TrendsTop Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
Top Ayurvedic PCD Companies in India Riding the Wave of Wellness Trends
muskansbl0159 views

Fraser Health Foot Care Project Shows Reduced Amputation, Hospitalization and Length of Stay in Dialysis Patients

  • 1. 2015 Foot Care Initiative in Dialysis Patients Fraser Health Authority Dr Shaoyee Yao
  • 2. Background Burden of Lower Limb disease Lower limb disease affects 30-40% of prevalent dialysis patients Ndip,A et al. Diabetes Care 2010
  • 3. Background Lower limb disease associated with significant morbidity and mortality in dialysis patients Orimoto et al. J Vasc Surg 2013 5 year survival: 43% (CORR Data 2010) 5 year survival with foot lesion: 23%
  • 4. Background Kaminski M Et al. NDT 2015 Can we alter these risk factors to improve outcomes ?
  • 5. Project Intent • To establish a multi disciplinary approach to early detection and treatment of lower limb lesions in patients with ESRD
  • 6. Project Outline Pilot at ARH over 2 years duration measuring outcomes before and after intervention Outcomes of interest: 1. Rates of limb amputation 2. Days of hospitalization per year 3. All cause mortality
  • 8. “Socks Off Week” ’60 Second’ Foot assessment: performed on all dialysis patients by Renal RN every 6 weeks
  • 11. Hospitalization rate by complication – ARH HD + PD Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%)   n (%) n (%) Lower Limb Infection  17 (8.9%) 8 (4.4%) (-) 9 ↓ 50.6% Lower limb revascularization  4 (2.1%) 4 (2.2%) 0 ↑ 4.8% Peripheral Vascular Disease  8 (4.2%) 12 (6.6%) (+) 4 ↑ 57.1% Lower limb angiogram 1 (0.53%) 2 (1.1%) (+) 1 ↑ 108% Hospitalization rate – discharges excluding amputation (Lower limb infection, LL revascularization, LL angiogram, PVD) 30 (15.8%) 26 (14.2%) (-) 4 ↓ 10.1% Hospitalization rate - discharges including amputation 36 (18.9%) 32 (17.5%) (-) 4 ↓ 7.4% Amputation Rate - ARH HD + PD   Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%) Amputation rate (# patients with amp event / total pts) 2.6% 1.6% --- ↓ 38.5% Preliminary Results – 1 Decreased 687  days in hospital  for lower limb  related  admissions! Hospitalization days - ARH HD + PD Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Relative Difference (%) Total days (all events excluding amputation)  1080 834 (-) 246 --- Hospital days Per person 5.68 4.56 --- ↓ 19.7% Total days (all events including amputation) 1718 1031 (-) 687 --- Hospital days Per person 9.04 5.63 --- ↓ 37.7% Average Length of Stay - ARH HD + PD Pre Intervention (N=190) Post Intervention (N=183) Absolute Difference Amputation only 36.0 32.1 (-) 3.9 Other reasons  (Lower limb infection, Lower limb  Revascularization, Lower limb Angiogram, PVD) 106.3 32.8 (-) 73.5
  • 12. Hospitalization rate by complication - HD + PD Post RCH + SMH (N=600) Post ARH (N=183) Absolute Difference Relative Difference (%)   n (%) n (%) Lower Limb Infection  51 (8.5%) 8 (4.4%) --- ↓ 48.2% Lower limb revascularization  26 (4.33%) 4 (2.2%) --- ↓ 49.2% Peripheral Vascular Disease  39 (6.5%) 12 (6.6%) --- ↑ 1.5% Lower limb angiogram 4 (.7%) 2 (1.1%) --- ↑ 44.7% Hospitalization rate – discharges excluding amputation (Lower limb infection, LL revascularization, LL angiogram, PVD) 120 (20.0%) 26 (14.2%) --- ↓ 29.0% Hospitalization rate - discharges including amputation 145 (24.2%) 32 (17.5%) --- ↓ 27.7% Amputation Rate - HD + PD   Post RCH + RCH (N=600) Post ARH (N=183) Absolute Difference Relative Difference (%) Amputation rate (# patients with amp event / total pts) 3.0% 1.6% --- ↓ 46.7% Preliminary Results - 2 Hospitalization days - HD + PD Post RCH + SMH (N=600) Post ARH (N=183) Absolute Difference Relative Difference (%) Total days (all events excluding amputation)  4362 834   --- Hospital days Per person 7.27 4.56 --- ↓ 37.3% Total days (all events including amputation) 5914 1031   --- Hospital days Per person 9.86 5.63 --- ↓ 42.9% Average Length of Stay - HD + PD Post RCH + SMH (N=600) Post ARH (N=183) Absolute Difference Amputation only 62.1 32.8 (-) 29.3 Other reasons  (Lower limb infection, Lower limb  Revascularization, Lower limb Angiogram, PVD) 36.4 32.1 (-) 4.3
  • 13. Preliminary Results -3 Mortality  ARH Pre Intervention RCH + SMH Post ARH Post Intervention N= 190 600 183 Event data end date 30-Nov-13 # Patients Deceased on or  before event data end date 34 105 26 Rate 17.9% 17.5% 14.2% 30-Nov-14
  • 15. Costs  Service Cost (Dec 1, 2013- Nov 30, 2014) Podiatry:  Partial MSP covered ($23 / visit)  $150/new consult , $79/follow up  $44 080.50 Unit Clerk  $1198.40 Nursing Project Coordinator  (with hours for Nurse Champion) $35 609.96 TOTAL $80 888.76
  • 16. Next Steps • Pilot continues until Dec 1, 2015 (2 years) • Final data expected May 2016 • Expansion of intervention to SMH and RCH • Perform cost benefit analysis • Coordinate with the BCPRA to create a province wide strategy
  • 17. Thank You • Sarah Lacroix (Project Coordinator) • Dr Scott Schumacher (Podiatrist) • Welman Lee, Dr Daniel Schwartz, Ruth Burns, Jan Olsen • All the Renal Nurses at ARH!!

Editor's Notes

  1. NDIP, A et al. Diabetes care 2010
  2. Long term follow up study on 234 hemodialysis patients in japan (followed up 1980 -2011), 31 year follow up Shows very poor rates of survival in ESRD patients with a foot lesion Revascularization did not improve survival but there was biased in selection of patients revascularized
  3. The meta analysis of over 48 000 dialysis patients and these factors listed about were shown to have statiscal significance in this population